01943nam a22007337a 4500 823 823 D0001C000035 DOH 20200806155507.0 200528b ph ||||| |||| 00| 0 eng d DOH Remdesivir in adults with severe COVID-19 : a randomised, double-blind, placebo-controlled, multicentre trial / Yeming Wang [and forty one others] In: The Lancet, 2020 Vol. 395 (10236) page 1569-1578 Nucleosides Prodrugs Coronavirus Remdesivir COVID-19 Wang, Yeming Zhang, Dingyu Du, Guanhua Du, Ronghui Zhao, Jianping Jin, Yang Fu, Shouzhi Gao, Ling Cheng, Zhenshun Lu, Qiaofa Wang, Ke Lu, Yang Li, Huadong Wang, Shuzhen Ruan, Shunan Yang, Chengqing Mei, Chunlin Wang, Yi Ding, Dan Wu, Feng Tang, Xin Ye, Xianzhi Ye, Yingchun Liu, Bing Yang, Jie Yin, Wen Wang, Aili Fan, Guohui Zhou, Fei Liu, Zhibo Gu, Xiaoying Xu, Jiuyang Shang, Lianhan Zhang, Yi Cao, Lianjun Guo, Tingting Wan, Yan Qin, Hong Jiang, Yushen Jaki, Thomas Hayden, Frederick G. Horby, Peter W. Cao, Bin Wang, Chen https://www.thelancet.com/action/showPdf?pii=S0140-6736%2820%2931022-9 CV